Mahavir Advanced Remedies Ltd - Stock Valuation and Financial Performance

BSE: 531689 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on IndoAmerican Advance

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

2. Valuation

Undervalued

3. Price Trend

Mahavir Advanced Remedies stock performance -

mw4me loader
P/E Ratio (SA):
660.72
Market Cap:
171.1 Cr.
52-wk low:
150.7
52-wk high:
150.7

Is Mahavir Advanced Remedies Ltd an attractive stock to invest in?

1. Is Mahavir Advanced Remedies Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Mahavir Advanced Remedies Ltd is a below average quality company.

2. Is Mahavir Advanced Remedies Ltd undervalued or overvalued?

No data found

3. Is Mahavir Advanced Remedies Ltd a good buy now?

No data found

10 Year X-Ray of IndoAmerican Advance:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Mahavir Advanced Remedies Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
ROCE % 0%0%0%0%0%-11.4%-6.2%-39.3%-3.3%1.6%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 000000.20.20.20.10.10
Sales YoY Gr.-NANANANANA26.3%-12.5%-33.3%-28.6%-
Adj EPS 00000-0.1-0.1-0.2-0.10.10.2
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 000001.52.41.57.67.77.9
Adj Net
Profit
00000-0.1-0.1-0.1-0.20.10
Cash Flow from Ops. 00000000-8.20.5-
Debt/CF from Ops. 0000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA-25.3%-28.6%
Adj EPS NANANANA
BVPSNANA48.6%1.6%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
Return on
Equity %
00000-6.7-5-10.1-3.31.63
Op. Profit
Mgn %
00000-9.4-3.19.4-118-778.6
Net Profit
Mgn %
00000-32.8-19.6-39.2-112.1133.9130.6
Debt to
Equity
0000000000-
Working Cap
Days
0000005961,11512,46930,0699,856
Cash Conv.
Cycle
000000-386761181899,848

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 3.00%

Sales growth is good in last 4 quarters at 75.00%

Sales growth has been subdued in last 3 years -25.31%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Mahavir Advanced Remedies Ltd.

Standalone Consolidated
TTM EPS (₹) 0.2 -
TTM Sales (₹ Cr.) 0.2 -
BVPS (₹.) 7.9 -
Reserves (₹ Cr.) -2 -
P/BV 19.18 -
PE 660.72 -
From the Market
52 Week Low / High (₹) 150.65 / 150.65
All Time Low / High (₹) 7.30 / 374.10
Market Cap (₹ Cr.) 171
Equity (₹ Cr.) 11.4
Face Value (₹) 10
Industry PE 44.3

Management X-Ray of IndoAmerican Advance:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of IndoAmerican Advance

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14
Sales00000
Operating Expenses 00100
Manufacturing Costs00000
Material Costs00000
Employee Cost 00000
Other Costs 00000
Operating Profit 00000
Operating Profit Margin (%) -9.4%-3.1%-152.0%-118.0%-77.0%
Other Income 00000
Interest 00000
Depreciation 00000
Exceptional Items 00000
Profit Before Tax 00000
Tax 00000
Profit After Tax 00000
PAT Margin (%) -32.8%-19.6%-152.0%-112.0%133.9%
Adjusted EPS (₹)-0.2-0.1-0.8-0.10.1
Dividend Payout Ratio (%)0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14

Equity and Liabilities

Shareholders Fund 11199
Share Capital 4441111
Reserves -3-3-3-3-3
Minority Interest00000
Debt00000
Long Term Debt00000
Short Term Debt00000
Trade Payables00000
Others Liabilities 00000
Total Liabilities 11199

Fixed Assets

Gross Block10000
Accumulated Depreciation00000
Net Fixed Assets00000
CWIP 00000
Investments 00000
Inventories00000
Trade Receivables00000
Cash Equivalents 00000
Others Assets00198
Total Assets 11199

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14
Cash Flow From Operating Activity 000-80
PBT 00000
Adjustment 00000
Changes in Working Capital 0-0-0-80
Tax Paid 00000
Cash Flow From Investing Activity 00000
Capex 00000
Net Investments 00000
Others 00000
Cash Flow From Financing Activity 00080
Net Proceeds from Shares 00000
Net Proceeds from Borrowing 00000
Interest Paid 00000
Dividend Paid 00000
Others 00080
Net Cash Flow 00000
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14
Ratios
ROE (%)-11.46-6.57-43.46-3.321.58
ROCE (%)-11.44-6.24-39.33-3.281.58
Asset Turnover Ratio0.180.230.240.030.01
PAT to CFO Conversion(x)N/AN/AN/AN/AN/A
Working Capital Days
Receivable Days2141661872850
Inventory Days00000
Payable Days1750000

Mahavir Advanced Remedies Ltd Stock News

Mahavir Advanced Remedies Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of IndoAmerican Advance on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of IndoAmerican Advance stood at ₹171.1.
The latest P/E ratio of IndoAmerican Advance as of 01-Jan-1970 05:30 is 660.7.
The latest P/B ratio of IndoAmerican Advance as of 01-Jan-1970 05:30 is 19.18.
The 52-week high of IndoAmerican Advance is ₹150.7 and the 52-week low is ₹150.7.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of IndoAmerican Advance is ₹0.20 ( Cr.) .

About Mahavir Advanced Remedies Ltd

Indo American Advanced Pharmaceuticals was incorporated on April 29, 1992 was set up to make branded and generic formulations under different systems of medicine such as allopathy, ayurveda and siddha. The company was earlier known as Indo American Advance Pharmaceuticals, it got its present name on December 20, 1996.

The company is located in the Nellore District of Andhra Pradesh, the manufacturing facility was established for manufacturing a variety of formulations including tablets, capsules, liquids and ointments in the field of antibiotics, analgesics, anti-pyretic, antibacterial, anti-inflammatory, and other genres. The company has been suspended from the BSE on account of non-compliance with the listing agreement clauses.

The registered office of the company is located at 24, 2nd Floor, Railway Colony, III Street, NMM Road, Chennai-600029, Tamil Nadu.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.